ESMO 2025

Featuring:

• Consultant Clinical Oncologist, Royal Cornwall HospitalDr. John McGraneexpand_more

  Dr. John McGrane has been working as a consultant clinical oncologist at the Royal Cornwall Hospital since 2014. He serves as the clinical lead for radiotherapy at the Royal Cornwall Hospital and specializes in radiotherapy and systemic anti-cancer treatment for urological and gynecological cancers.

  In addition to his clinical practice, Dr. McGrane is actively involved in recruiting participants for clinical trials in the fields of urological and gynecological cancers at the Royal Cornwall Hospital. He holds the position of UK Chief Investigator in the IMReal urothelial immunotherapy study and oversees several urological and gynecological trials as Principal Investigator for over 25 clinical trials.

  Dr. McGrane is a co-founder of the UK Renal Oncology Collaboration, which focuses on Real World Evidence in renal cancer. He is also a member of the UK Renal Oncology Group and is dedicated to enhancing the profile of renal cancer and encouraging participation in clinical trials.

  Additionally, Dr. McGrane has a keen interest in digital health solutions for cancer patient follow-up and care. In 2018, he co-founded the award-winning MySunrise cancer patient support app, which is currently active throughout the South West and West Midlands.

• Consultant Medical Oncologist, St Barts HospitalDr. Kenrick Ngexpand_more

  Dr. Kenrick Ng is a Consultant in Medical Oncology and Clinical Director for Inpatient Care at Barts Cancer Centre, St Bartholomew’s Hospital. He is also Editor-in-chief of the journal Oncology and Therapy. He obtained his medical degree from the University of Cambridge in 2012, further to completing a PhD in Tumour Immunology between 2018-2021 in the UCL Cancer Institute under a Cancer Research UK Clinical Research Training Fellowship.

  He is currently tumour group lead for prostate cancer in Barts Cancer Centre, London and UK chief investigator and principal investigator for several early and late phase trials in prostate cancer.

  He has also received research grants from the UK Medical Research Council, Prostate Cancer Research, Cancer Research UK Early Detection Scheme and the Cancer Research UK Cancer Development Fund. He has published more than 70 peer-reviewed articles and book chapters. His research work in prostate cancer has been awarded with the Helen Patterson Research Registrar Award and ASCO Conquer Cancer Foundation Merit Award.